Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine
Hepatic epithelioid hemangioendothelioma (HEH) is extremely rare, occurring in 1 to 2 per 100,000, with chemotherapy options not well defined. Our case involved a 49-year-old female who had hepatic masses and metastasis to the lungs with a liver biopsy revealing HEH. After developing a rash from sor...
Saved in:
| Main Authors: | Matthew P. Soape, Rashmi Verma, J. Drew Payne, Mitchell Wachtel, Fred Hardwicke, Everardo Cobos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Gastrointestinal Medicine |
| Online Access: | http://dx.doi.org/10.1155/2015/326795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Epithelioid Hemangioendothelioma
by: I. Z. Korobkova, et al.
Published: (2020-01-01) -
Hepatic Endometriosis Misdiagnosed as Hepatic Epithelioid Hemangioendothelioma
by: Aditya Kler, et al.
Published: (2025-01-01) -
Laparoscopic repeat liver resection for hepatic epithelioid hemangioendothelioma
by: Fumihiro Terasaki, et al.
Published: (2020-10-01) -
Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma
by: Mira M. Lotfalla, et al.
Published: (2019-01-01) -
Hepatic Epithelioid Hemangioendothelioma and the Danger of Misdiagnosis: Report of a Case
by: Kyriakos Neofytou, et al.
Published: (2013-01-01)